Zhou Zhi-wei

Biography

Dr. Zhi-wei Zhou is professor and director in the Department of Gastric and Pancreatic Surgery in Sun Yat-sen University Cancer Center（SYSUCC）. Dr. Zhou obtained his Bachelor in Medicine (equivalent to MD in the US) and PhD at Sun Yat-sen University of Medical Sciences, P. R. China in 1984 and 2007, respectively. He started his residency training in Chinese-Japanese Friendship Hospital in Beijing in 1984 and continued residency in Department of Abdominal Surgery in Sun Yat-sen University Cancer Center from 1986 to 1991. He was promoted to be attending surgeon, associate professor, professor in 1991, 1998 and 2004, respectively. He has been working on and gained lots of experience in the diagnosis and treatment of abdominal malignancies (including gastric cancer, colorectal cancer, pancreatic cancer, retroperitoneal tumors and gastrointestinal tumors), soft tissue malignancies and melanoma for over 30 years, especially the surgical treatment and adjuvant chemotherapy for gastric cancer. Dr. Zhou was appointed as the director of Department of Gastric and Pancreatic Surgery in SYSUCC in 2009 and elected to be the president of Gastric Cancer Speciality Committee of Guangdong Provincial Anti-cancer Association in 2012. His current focus in clinical work is to improve the early diagnosis and multidisciplinary treatments for gastric cancer and to conduct laparoscopic surgeries on gastric cancer patients. His current focus in research work is to study neoadjuvant chemotherapy, chemoradiation and molecular typing for gastric cancer. Dr. Zhou has published 3 editorial books and more than 30 research papers.

Research Interest

Neoadjuvant chemotherapy for advanced gastric cancer: conduct both basic and clinical research (including prospective randomized controlled clinical trials) on neoadjuvant chemotherapy for advanced gastric cancer, in order to learn indications and effective regimens of neoajuvant chemotherapy for advanced gastric cancer. Chemoradiation for locally advanced gastric cancer: Conduct both basic and clinical research on chemoradiation for locally advanced gastric cancer in order to gain some experience in this field for currently in China no consensus are reached on the efficacy of chemoradiation in gastric cancer.  Translational research on molecular typing of gastric cancer: Explore molecular types of gastric cancer by gene chips, tissue microarray technology and so on in order to better predict prognosis of gastric cancer patients and evaluate their sensitivity to chemotherapy and/or radiotherapy.